These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6587212)
21. The pharmacoeconomic benefits of cholesterol reduction. Gonzalez ER Am J Manag Care; 1998 Feb; 4(2):223-30. PubMed ID: 10178493 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia. Denke MA; Grundy SM Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022 [TBL] [Abstract][Full Text] [Related]
23. An effective treatment of hypercholesterolaemia. Use of a combination of a bile acid sequestrant and clofibrate. Howard AN; Evans RJ; Hyams DE Med Chir Dig; 1972; 1(5):235-9. PubMed ID: 4631445 [No Abstract] [Full Text] [Related]
24. Diet and coronary heart disease. Med Lett Drugs Ther; 1985 Jan; 27(678):1. PubMed ID: 3965920 [No Abstract] [Full Text] [Related]
26. [Hypercholesterinemia: treatment with Colestyramin]. Weizel A Fortschr Med; 1972 Jun; 90(18):715-8. PubMed ID: 5082079 [No Abstract] [Full Text] [Related]
27. Letter: Possible ineffective use of cholestyramine. Pain RW Med J Aust; 1975 Jan; 1(1):21. PubMed ID: 1128335 [No Abstract] [Full Text] [Related]
28. Free care, cholestyramine, and health policy. Himmelstein DU; Woolhandler S N Engl J Med; 1984 Dec; 311(23):1511-4. PubMed ID: 6438506 [No Abstract] [Full Text] [Related]
29. Treatment guidelines for hypercholesterolemia. Howard PA J Pract Nurs; 1991 Mar; 41(1):15-23. PubMed ID: 2046030 [No Abstract] [Full Text] [Related]
30. [On the treatment of hyperlipoproteinaemia type II with cholestyramine (author's transl)]. Válek J; Pechar J; Hrubá F Cas Lek Cesk; 1973 Dec; 112(49):1531-4. PubMed ID: 4358602 [No Abstract] [Full Text] [Related]
31. The decrease in coronary heart disease mortality. Status and perspectives on the role of cholesterol. Am J Cardiol; 1984 Aug; 54(5):35C-41C. PubMed ID: 6148006 [No Abstract] [Full Text] [Related]
32. Treatment of children with familial hypercholesterolaemia. West RJ; Fosbrooke AS; Lloyd JK Postgrad Med J; 1975; 51(8):suppl 82-7. PubMed ID: 1052928 [No Abstract] [Full Text] [Related]
33. Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia. Xydakis AM; Guyton JR; Chiou P; Stein JL; Jones PH; Ballantyne CM Am J Cardiol; 2004 Sep; 94(6):795-7. PubMed ID: 15374793 [TBL] [Abstract][Full Text] [Related]
34. Time to treat cholesterol seriously. Nestel PJ Aust N Z J Med; 1984 Jun; 14(3):198-9. PubMed ID: 6594110 [No Abstract] [Full Text] [Related]
35. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia]. Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396 [TBL] [Abstract][Full Text] [Related]
40. New drugs for the treatment of hypercholesterolemia. Hamlin JT Va Med Mon (1918); 1969 Jan; 96(1):11-2. PubMed ID: 5763103 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]